Literature DB >> 1434052

[Serum lipids, lipoproteins and apolipoproteins in patients with senile dementia].

M Kuriyama1, Y Hokezu, S Togo, K Nagata, K Takahashi, T Igakura, M Osame.   

Abstract

Serum lipid, lipoprotein, apolipoprotein, and sterol profiles were studied in 22 patients with senile dementia of the Alzheimer type (SDAT) and 29 patients with vascular dementia (VD). Levels of high density lipoprotein-cholesterol (HDL-C) were lower in both patients groups of SDAT and VD than in control group. Apolipoprotein AI and AII are two major proteins in HDL. In this study, apolipoprotein AI levels were normal, but apolipoprotein AII levels were lower in the patient groups, especially in the VD group, than in the control group. Lipoprotein(a) levels were higher in both patient groups, especially in the VD group. There were no differences of cholesterol, cholesterol precursors (desmosterol and lathosterol), and plant sterols (campesterol and beta-sitosterol) among the three groups. Murine apolipoprotein AII is a serum precursor of murine senile amyloid protein, and the apolipoprotein AII variant with proline-->glutamine substitution at position 5 in the serum of accelerated senescence-prone mice is identical to the murine senile amyloid fibril protein from amyloid-deposited tissues of these mice. In human SDAT and VD, the reason for the low level of apolipoprotein AII remains unclear.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1434052     DOI: 10.3143/geriatrics.29.559

Source DB:  PubMed          Journal:  Nihon Ronen Igakkai Zasshi        ISSN: 0300-9173


  8 in total

1.  Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis.

Authors:  M A Beydoun; H A Beydoun; Y Wang
Journal:  Obes Rev       Date:  2008-03-06       Impact factor: 9.213

Review 2.  Intersection between metabolic dysfunction, high fat diet consumption, and brain aging.

Authors:  Romina M Uranga; Annadora J Bruce-Keller; Christopher D Morrison; Sun Ok Fernandez-Kim; Philip J Ebenezer; Le Zhang; Kalavathi Dasuri; Jeffrey N Keller
Journal:  J Neurochem       Date:  2010-05-06       Impact factor: 5.372

3.  Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease.

Authors:  Christiane Reitz; Ming-Xin Tang; Nicole Schupf; Jennifer J Manly; Richard Mayeux; José A Luchsinger
Journal:  Arch Neurol       Date:  2010-12

4.  Impact of plasma lipids and time on memory performance in healthy elderly without dementia.

Authors:  C Reitz; J Luchsinger; M-X Tang; J Manly; R Mayeux
Journal:  Neurology       Date:  2005-04-26       Impact factor: 9.910

5.  Association of Circulating Apolipoprotein AI Levels in Patients With Alzheimer's Disease: A Systematic Review and Meta-Analysis.

Authors:  Jun-Hui Tong; Shi-Qiang Gong; Yan-Song Zhang; Jian-Ru Dong; Xin Zhong; Min-Jie Wei; Ming-Yan Liu
Journal:  Front Aging Neurosci       Date:  2022-05-18       Impact factor: 5.702

6.  Relation of plasma lipids to Alzheimer disease and vascular dementia.

Authors:  Christiane Reitz; Ming-Xin Tang; Jose Luchsinger; Richard Mayeux
Journal:  Arch Neurol       Date:  2004-05

7.  Association of adiposity status and changes in early to mid-adulthood with incidence of Alzheimer's disease.

Authors:  May A Beydoun; April Lhotsky; Youfa Wang; Gloria Dal Forno; Yang An; E Jeffrey Metter; Luigi Ferrucci; Richard O'Brien; Alan B Zonderman
Journal:  Am J Epidemiol       Date:  2008-10-03       Impact factor: 4.897

8.  Lipoprotein profile in older patients with vascular dementia and Alzheimer's disease.

Authors:  G Zuliani; A Ble'; R Zanca; M R Munari; A Zurlo; C Vavalle; A R Atti; R Fellin
Journal:  BMC Geriatr       Date:  2001       Impact factor: 3.921

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.